The results of a new study designed to compare the severity and timing of perimenstrual symptoms among women who do or do not use cyclic hormonal contraception are reported in Journal of Women’s Health.

The article entitled “The Influence of Cyclic Hormonal Contraception on Expression of Premenstrual Syndrome” is coauthored by Journal of Women’s Health Editor-in-Chief Susan Kornstein, Executive Director of the Virginia Commonwealth University Institute for Women’s Health, Richmond, VA, Kimberly Yonkers, MD and Margaret Altemus, MD, Yale University School of Medicine, and Brianna Cameron and Ralitza Gueorguieva, PhD, Yale University School of Public Health, New Haven, CT.“Because women taking hormonal contraceptives are routinely excluded from studies of PMS and premenstrual dysphoric disorder (PMDD), this study provides a valuable examination of the influence of exogenous hormones on premenstrual symptom expression and response to treatment,” says Robert Downs, MD, Deputy Editor of Journal of Women’s Health, Richmond, VA.

Source: Mary Ann Liebert, Inc., Publishers
Full bibliographic information:
The Influence of Cyclic Hormonal Contraception on Expression of Premenstrual Syndrome
Journal of Women’s Health. November 2016, ahead of print.